Literature DB >> 6456289

Differential effects of cognitive therapy and pharmacotherapy on depressive symptoms.

A J Rush, M Kovacs, A T Beck, J Weissenburger, S D Hollon.   

Abstract

Patterns of symptoms change were examined in 35 unipolar depressed outpatients treated with either cognitive therapy or pharmacotherapy (imipramine HCl). Cross-lagged panel analyses were used to evaluate the temporal relationships among changes in views of the self, hopelessness, mood, motivation and vegetative symptoms during treatment weeks 1-4. During cognitive therapy improvements in hopelessness, views of the self and mood generally preceded changes in vegetative and motivational symptoms. On the other hand, no consistent pattern of change was associated with pharmacotherapy. While these results are compatible with the notion that cognitive therapy initially alters negative thinking and mood, which secondarily leads to improvements in vegetative and motivational symptoms, further studies with a placebo or wait-list group are needed to determine if this is a unique effect of cognitive therapy.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6456289     DOI: 10.1016/0165-0327(81)90024-0

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  10 in total

Review 1.  Targeted electrode-based modulation of neural circuits for depression.

Authors:  Helen S Mayberg
Journal:  J Clin Invest       Date:  2009-04       Impact factor: 14.808

Review 2.  The neuropsychology of depression and its implications for cognitive therapy.

Authors:  W D Crews; D W Harrison
Journal:  Neuropsychol Rev       Date:  1995-06       Impact factor: 7.444

3.  A Propensity Score Analysis of Homework Adherence-Outcome Relations in Cognitive Behavioral Therapy for Depression.

Authors:  Judith A Callan; Nikolaos Kazantzis; Seo Young Park; Charity G Moore; Michael E Thase; Abu Minhajuddin; Sander Kornblith; Greg J Siegle
Journal:  Behav Ther       Date:  2018-06-05

4.  Sequence of improvement in depressive symptoms across cognitive therapy and pharmacotherapy.

Authors:  Sunil S Bhar; Lois A Gelfand; Sabine P Schmid; Robert Gallop; Robert J DeRubeis; Steven D Hollon; Jay D Amsterdam; Richard C Shelton; Aaron T Beck
Journal:  J Affect Disord       Date:  2008-02-13       Impact factor: 4.839

5.  Changes in cognitive content during and following cognitive therapy for recurrent depression: substantial and enduring, but not predictive of change in depressive symptoms.

Authors:  Robin B Jarrett; Jeffrey R Vittengl; Kimberly Doyle; Lee Anna Clark
Journal:  J Consult Clin Psychol       Date:  2007-06

6.  Discontinuities and cognitive changes in an exposure-based cognitive therapy for depression.

Authors:  Adele M Hayes; Greg C Feldman; Christopher G Beevers; Jean-Philippe Laurenceau; LeeAnn Cardaciotto; Jamie Lewis-Smith
Journal:  J Consult Clin Psychol       Date:  2007-06

7.  Pediatric psychopharmacology: too much or too little?

Authors:  Judith L Rapoport
Journal:  World Psychiatry       Date:  2013-06       Impact factor: 49.548

8.  Differential change in specific depressive symptoms during antidepressant medication or cognitive therapy.

Authors:  Jay C Fournier; Robert J DeRubeis; Steven D Hollon; Robert Gallop; Richard C Shelton; Jay D Amsterdam
Journal:  Behav Res Ther       Date:  2013-04-12

9.  Youth Top Problems and Early Treatment Response to the Unified Protocols for Transdiagnostic Treatment of Emotional Disorders in Children and Adolescents.

Authors:  Lauren Milgram; Niza A Tonarely; Jill Ehrenreich-May
Journal:  Child Psychiatry Hum Dev       Date:  2021-03-17

10.  Mechanisms of change and heterogeneous treatment effects in psychodynamic and cognitive behavioural therapy for patients with depressive disorder: a randomized controlled trial.

Authors:  J I Røssberg; J Evensen; T Dammen; T Wilberg; O Klungsøyr; M Jones; E Bøen; R Egeland; R Breivik; A Løvgren; R Ulberg
Journal:  BMC Psychol       Date:  2021-01-22
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.